UK
2025
You're invited to our live expert panel and Q&A
The Australian Advantage for early phase clinical studies
Attend our Tea & Talk Series taking place in Oxford and Cambridge on 12th and 13th of March. Join us for either breakfast or afternoon tea at one of our seminars.
Participating Companies:
Upcoming events details
Oxford: Tea & Talks Morning Seminar The Oxford Science Park - Sadler Building - Thames Room
12 March, 2025 (Wed)
9:00 - 10:30am
Milton: Tea & Talks Afternoon Seminar Milton Park (MEPC) - Bee House
12 March, 2025 (Wed)
3:00 - 4:30pm
Stevenage: Tea & Talks Lunch & Learn Seminar Stevenage Bioscience Catalyst - Boardroom
13 March, 2025 (Thu)
12:00-1:30pm
Cambridge: Tea & Talks Afternoon Seminar One Nucleus - Babraham Campus
13 March, 2025 (Thu)
3:00 - 4:30pm
Panel speakers
Chris Stellatos
Director, Business &
Corporate Development
Scientia Clinical Research (SCR)
Scientia Clinical Research (SCR) is the first and only dedicated Phase I clinical trial unit, centrally located in Sydney that operates as a Not For Profit. With the ability to engage participants on a 24/7 basis, our goal is to help sponsors accelerate their development, simplify their Phase I study and generate results that are accepted by all major regulators.
Panel speakers
Chris Stellatos
Director, Business &
Corporate Development
Scientia Clinical Research (SCR)
Scientia Clinical Research (SCR) is the first and only dedicated Phase I clinical trial unit, centrally located in Sydney that operates as a Not For Profit. With the ability to engage participants on a 24/7 basis, our goal is to help sponsors accelerate their development, simplify their Phase I study and generate results that are accepted by all major regulators.
Chris Stellatos
Director, Business &
Corporate Development
Scientia Clinical Research (SCR)
Scientia Clinical Research (SCR) is the first and only dedicated Phase I clinical trial unit, centrally located in Sydney that operates as a Not For Profit. With the ability to engage participants on a 24/7 basis, our goal is to help sponsors accelerate their development, simplify their Phase I study and generate results that are accepted by all major regulators.
Chris Stellatos
Director, Business &
Corporate Development
Scientia Clinical Research (SCR)
Scientia Clinical Research (SCR) is the first and only dedicated Phase I clinical trial unit, centrally located in Sydney that operates as a Not For Profit. With the ability to engage participants on a 24/7 basis, our goal is to help sponsors accelerate their development, simplify their Phase I study and generate results that are accepted by all major regulators.
Proudly Supported By:
